Skip to main content

Advertisement

SpringerLink
Log in

Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren contracture: report of 40 cases

  • Original Article
  • Published:
MUSCULOSKELETAL SURGERY Aims and scope Submit manuscript

Abstract

Background

Dupuytren’s disease (DD) is a fibroproliferative pathology that affects the palmar aponeurosis causing the development of nodules and collagen cords and the progressive flexion of the fingers. The standard procedure is surgical fasciectomy, followed by high recurrence rates. Collagenase Clostridium histolyticum (CCH) injection represents an innovative noninvasive approach to the treatment of DD. This prospective study was designed to examine the efficacy and safety of CCH injection performed in the outpatient, using local anesthesia.

Materials and methods

Forty patients [32 metacarpophalangeal (MP), 8 proximal interphalangeal (PIP)] with Dupuytren’s contracture of at least 20° for MP joint and any degree for PIP joint were included. The mean age was 66. All joints were treated with a single vial of collagenase injection and manual breaking of the cord 24 h after. All adverse effects (AEs) were monitored. Patients were checked 7, 30, 90, and 180 days after the injection. Primary endpoint was a reduction in digit contracture within 0°–5° of normal extension. Secondary endpoints were the improvement of range of motion, the evaluation of AEs incidence, and cost-effectiveness of collagenase treatment.

Results

About 67.5 % of patients obtained a clinical success. At 6 months, a further 7.5 % attained the same result. The mean contracture of treated joints was 5.3º for MP and 6.8° for PIP joints. Twenty-three patients had one or more mild-to-moderate side effects.

Conclusions

The use of collagenase appears to be an effective and safe method for the treatment of Dupuytren’s contracture. Therapeutic success was achieved in a significant percentage of patients. The incidence of side effects was higher, but they were local reactions of short duration. The use of a single collagenase vial in patients treated in day surgery appears more cost-effective than surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

CCH:

Collagenase Clostridium histolyticum

MCP:

Metacarpophalangeal joint

PIP:

Proximal interphalangeal joint

PCRT:

Placebo-controlled randomized trial

AE:

Adverse effects

References

  1. Canale ST (2003) Campbell’s Operative Orthopaedics, vol 4, 10th edn.

  2. Rayan GM (2007) Dupuytren’s disease: anatomy, pathology, presentation, and treatment. J Bone Joint Surg Am 89(1):189–198

    PubMed  Google Scholar 

  3. Shaw RB Jr, Chong AK, Zhang A, Hentz VR, Chang J (2007) Dupuytren’s disease: history, diagnosis, and treatment. Plast Reconstr Surg 120(3):44–54

    Article  Google Scholar 

  4. Smith AC (1991) Diagnosis and indications for surgical treatment. Hand Clin 7:635–642

    CAS  PubMed  Google Scholar 

  5. Mafi R, Hindocha S, Khan W (2012) Recent surgical and medical advances in the treatment of Dupuytren’s disease—a systematic review of the literature. Open Orthop J 6(Suppl 1:M9):77–82

    Article  Google Scholar 

  6. Crean SM, Gerber RA, Le Graverand MP, Boyd DM, Cappelleri JC (2011) The efficacy and safety of fasciectomy and fasciotomy for Dupuytren’s contracture in European patients: a structured review of published studies. J Hand Surg Eur Vol 36:396–407

    Article  CAS  PubMed  Google Scholar 

  7. Witthaut J, Jones G, Skrepnik N, Kushner H, Houston A, Lindau TR (2013) Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies. J Hand Surg 38(1):2-11

    Google Scholar 

  8. Chen NC, Srinivasan RC, Shauver MJ, Chung KC (2011) A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren’s contracture. Hand 6(3):250–255

    Article  PubMed Central  PubMed  Google Scholar 

  9. Werker PM, Pess GM, van Rijssen AL, Denkler K (2012) Correction of contracture and relapse rates of Dupuytren contracture following invasive treatment: the importance of clear definitions. J Hand Surg Am 37(10):2095–2105

    Article  PubMed  Google Scholar 

  10. Tripoli M, Cordova A, Moschella F (2010) The ‘‘Jacobsen Flap’’ technique: a safe, simple surgical procedure to treat Dupuytren disease of the little finger in advanced stage. Tech Hand Up Extrem Surg 14:173–177

    Article  PubMed  Google Scholar 

  11. Jacobsen K, Holst-Nielsen F (1977) A modified Mc Cash operation for Dupuytren’s contracture. Scand J Plast Reconstr Surg 11(3):231–233

    Article  CAS  PubMed  Google Scholar 

  12. Donaldson J, Goddar N (2012) The re-emergence of Percutaneous Fasciotomy in the Management of Dupuytren’s disease. Open Orthop J 6(Suppl 1: M10):83–87

    Article  PubMed Central  PubMed  Google Scholar 

  13. Thomas A, Bayat A (2010) The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease. Therap Clin Risk Manag 6:557–572

    Google Scholar 

  14. Hurst LC, Badalamente MA, Hentz VR, Hotchkiss RN, Kaplan FT, Meals RA, Smith TM, Rodzvilla J, CORD I Study Group (2009) Injectable collagenase Clostridium histolyticum for Dupuytren’s contracture. N Engl J Med 361(10):968–979

    Article  CAS  PubMed  Google Scholar 

  15. Gilpin D, Coleman S, Hall S, Houston A, Karrasch J, Jones N (2010) Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren’s disease. J Hand Surg Am 35(12):2027–2038

    Article  PubMed  Google Scholar 

  16. Peimer CA, Blazar P, Coleman S, Thomas F, Kaplan D, Smith T, Tursi JP, Cohen B, Kaufman GJ, Lindau T (2013) Dupuytren contracture relapse following treatment with collagenase Clostridium histolyticum (CORDLESS Study): 3-year data. J Hand Surg 38(1):12–22

    Article  Google Scholar 

  17. Foissac R, Camuzard O, Dumas P, Dumontier C, Chignon-Sicard B (2013) Treatment of Dupuytren’s contracture by collagenase injection. Chir Main 32(4):199–205

    Article  CAS  PubMed  Google Scholar 

  18. Witthaut J, Jones G, Skrepnik N, Kushner H, Houston A, Lindau TR (2013) Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies. J Hand Surg Am 38(1):2–11

    Article  PubMed  Google Scholar 

  19. Bainbridge C, Gerber RA, Szczypa PP, Smith T, Kushner H, Cohen B, Hellio Le Graverand-Gastineau MP (2012) Efficacy of collagenase in patients who did and did not have previous hand surgery for Dupuytren’s contracture. J Plast Surg Hand Surg 46(3–4):177–183

    Article  PubMed Central  PubMed  Google Scholar 

  20. Badalamente MA, Hurst LC (2007) Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren’s contracture. J Hand Surg Am 32(6):767–774

    Article  PubMed  Google Scholar 

  21. Watt AJ, Curtin CM, Hentz VR (2010) Collagenase injection as nonsurgical treatment of Dupuytren’s disease: 8-year follow-up. J Hand Surg Am 35(4):534–539

    Article  PubMed  Google Scholar 

  22. Badalamente MA, Hurst LC (1996) Enzyme injection as a nonoperative treatment for Dupuytren’s disease. Drug Deliv 3:35–40

    Article  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Hand Surgery, University Hospital of Verona, Policlinico GB Rossi, Piazzale LA Scuro 10, Verona, Italy

    F. Alberton, M. Corain, A. Garofano, L. Pangallo, A. Valore, V. Zanella & R. Adani

  2. U.O.C. Chirurgia della Mano, Policlinico G.B. Rossi Azienda Ospedaliera Universitaria Integrata Verona, p.zzle L.A. Scuro, 10, Verona, Italy

    R. Adani

Authors
  1. F. Alberton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Corain
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Garofano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Pangallo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Valore
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. V. Zanella
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. Adani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Adani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alberton, F., Corain, M., Garofano, A. et al. Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren contracture: report of 40 cases. Musculoskelet Surg 98, 225–232 (2014). https://doi.org/10.1007/s12306-013-0304-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12306-013-0304-x

Keywords

Search

Navigation